![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Tuesday, January 03, 2023 8:40:26 AM
Followers 164
Posts 23578
Boards Moderated 0
Alias Born 04/03/2010
biosectinvestor
Member Level
Re: exwannabe post# 555679
Tuesday, January 03, 2023 6:38:13 AM
Post#
555680
of 555697
This is false. The contract is cancelable by either party. There is a 12 month transition period for whomever to take over, whether NWBO, an acquirer, or another CDMO, whatever NWBO decides. The financing agreement is with NWBO, it has obligations to provide the some additional services to other companies with excess capacity, but the factory is for the manufacture of DCVax-L primarily. That was the purpose of the financing, that is the primary purpose of the CDMO agreement and all other facilitating agreements.
You can keep stating these false conclusions but they do not change reality.
The reality is that it is a project finance structure, it is modular, but it all relates to the primary purpose for the factory and for the factory, which is NWBO’s factory, for the manufacture of DCVax-L or any other DCVax product. The reality is these kinds of arrangements appear to random people sorting through contracts as though everything s chaotic and unrelated and that can allow for people on bulletin boards who have never done project finance to believe they can create mischief, suggest that there are ulterior motives and ulterior purposes. But that is all false. The core contract is the engagement of Advent as NWBO’s CDMO. There are no doubt some ambiguities, but it all works out in the end. The fig leaf people base these alternative viewpoints on is vague but not conclusive either. But no CDMO is going to remain where they are no longer needed. Both parties will make alternative arrangements. Some small space will be used for other parties, but that is not the purpose of the rest of and the bulk of the factory.
But the company can do the development of the factory as demand grows. They do not need to have it all built out today. This also allows people to suggest that this is all of it, and therefore … ulterior motives. But again, most of these theories are based on false presumptions and very slim notions excluding the full picture to assume bizarre theories.
Again, the applications, all the work, every piece of equipment, has been funded by NWBO, and the financing authority in a contract with NWBO. It is all at the disposal of NWBO as they need, but obviously, there will be some ongoing duty to the regional financing authority to provide additional services and if that business grows to any significance, at this point it is primarily speculative and a very young business, but if it grows, Advent can then likely lease space next door or nearby for those additional services to build their business. But that was not the purpose of the regional authority loan. It was first to finance NWBO’s factory and encourage development of a new sector in the local economy as well. But people can do these kinds of deals with regional development authorities without others implying it’s all crooked.
I own NWBO. My posts on iHub are always posted expressly as just my humble opinion (IMHO) and none are advice, just my opinion. I am NOT a financial advisor, and it is assumed that everyone is responsible for their own due diligence.
Recent NWBO News
- Biophma Announces Exclusive In License for Dendritic Cell Technology, Sending Shares Higher • AllPennyStocks.com • 06/17/2024 04:40:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/04/2024 09:11:16 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 06/03/2024 09:22:55 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 05/22/2024 08:13:36 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/10/2024 09:04:57 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/01/2024 10:04:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/02/2023 01:31:35 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 10:11:54 PM
- Epazz, Inc. (OTC Pink: EPAZ) ZenaDrone Demonstration to Defense Departments of UAE and Saudi Arabia • InvestorsHub NewsWire • 11/15/2023 12:19:31 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:30:39 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 • InvestorsHub NewsWire • 11/09/2023 01:00:34 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 Extreme Weather Demo • InvestorsHub NewsWire • 11/07/2023 12:29:43 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2023 08:36:14 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM